Literature DB >> 11852254

Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions.

Zachary Shriver1, Dongfang Liu, Ram Sasisekharan.   

Abstract

Heparan sulfate glycosaminoglycans (HSGAGs) are an important subset of complex polysaccharides that represent the third major class of biopolymer, along with polynucleic acids and polypeptides. However, the importance of HSGAGs in biological processes is underappreciated because of a lack of effective molecular tools to correlate specific structures with functions. Only recently have significant strides been made in understanding the steps of HSGAG biosynthesis that lead to the formation of unique structures of functional importance. Such advances now create possibilities for intervening in numerous clinical situations, creating much-needed novel therapies for a variety of pathophysiological conditions including atherosclerosis, thromboembolic disorders, and unstable angina.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852254     DOI: 10.1016/s1050-1738(01)00150-5

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  15 in total

Review 1.  Heparan sulfate-protein binding specificity.

Authors:  M A Nugent; J Zaia; J L Spencer
Journal:  Biochemistry (Mosc)       Date:  2013-07       Impact factor: 2.487

2.  Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.

Authors:  India C Severin; Jean-Philippe Gaudry; Zoë Johnson; Andreas Kungl; Ariane Jansma; Bernd Gesslbauer; Barbara Mulloy; Christine Power; Amanda E I Proudfoot; Tracy Handel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

3.  Bioengineering the infarcted heart by applying bio-inspired materials.

Authors:  Emil Ruvinov; Tamar Harel-Adar; Smadar Cohen
Journal:  J Cardiovasc Transl Res       Date:  2011-06-08       Impact factor: 4.132

4.  Regulation of xylosyltransferase I gene expression by interleukin 1β in human primary chondrocyte cells: mechanism and impact on proteoglycan synthesis.

Authors:  Mostafa Khair; Mustapha Bourhim; Lydia Barré; Dong Li; Patrick Netter; Jacques Magdalou; Sylvie Fournel-Gigleux; Mohamed Ouzzine
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

5.  Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation.

Authors:  Alison V Nairn; Akiko Kinoshita-Toyoda; Hidenao Toyoda; Jin Xie; Kyle Harris; Stephen Dalton; Michael Kulik; J Michael Pierce; Toshihiko Toida; Kelley W Moremen; Robert J Linhardt
Journal:  J Proteome Res       Date:  2007-10-04       Impact factor: 4.466

6.  Differentiating chondroitin sulfate glycosaminoglycans using collision-induced dissociation; uronic acid cross-ring diagnostic fragments in a single stage of tandem mass spectrometry.

Authors:  Muchena J Kailemia; Anish B Patel; Dane T Johnson; Lingyun Li; Robert J Linhardt; I Jonathan Amster
Journal:  Eur J Mass Spectrom (Chichester)       Date:  2015       Impact factor: 1.067

7.  LC-MS and LC-MS/MS studies of incorporation of 34SO3 into glycosaminoglycan chains by sulfotransferases.

Authors:  Xiaofeng Shi; Chun Shao; Yang Mao; Yu Huang; Zhengliang L Wu; Joseph Zaia
Journal:  Glycobiology       Date:  2013-05-21       Impact factor: 4.313

Review 8.  Current developments in adenovirus-based cancer gene therapy.

Authors:  Daniel T Rein; M Breidenbach; David T Curiel
Journal:  Future Oncol       Date:  2006-02       Impact factor: 3.404

9.  Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity.

Authors:  James R Myette; Venkataramanan Soundararajan; Zachary Shriver; Rahul Raman; Ram Sasisekharan
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

10.  Glycosaminoglycan analogs as a novel anti-inflammatory strategy.

Authors:  India C Severin; Adriano Soares; Jennifer Hantson; Mauro Teixeira; Daniela Sachs; Delphine Valognes; Alexander Scheer; Matthias K Schwarz; Timothy N C Wells; Amanda E I Proudfoot; Jeffrey Shaw
Journal:  Front Immunol       Date:  2012-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.